Animal models of epigenetic regulation in neuropsychiatric disorders

Current Topics in Behavioral Neurosciences

Volumn 7, Issue 1, 2011, Pages 281-322

  Bountra, Chas ^a   Oppermann, Udo ^a   Heightman, Tom D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Chromatin; Epigenetics; Histone modifying enzymes; Inhibitors

Indexed keywords

ACYLTRANSFERASE INHIBITOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DNA; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; HISTONE ACETYLTRANSFERASE INHIBITOR; HISTONE DEACETYLASE; HISTONE DEACETYLASE 5; HISTONE H3; HISTONE H4; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHYL CPG BINDING PROTEIN 2; METHYLTRANSFERASE; MICRORNA; UNCLASSIFIED DRUG; CHROMATIN; HISTONE;

ARTICLE; CHROMATIN STRUCTURE; CPG ISLAND; DEPRESSION; DIET; DISEASE MODEL; DNA METHYLATION; DNA METHYLTRANSFERASE 3A GENE; DNA METHYLTRANSFERASE 3B GENE; DRUG DEPENDENCE; ENZYME ACTIVITY; EPIGENETICS; EXPERIMENTAL ANIMAL; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC LINKAGE; GENETIC MARKER; GENETIC REGULATION; HISTONE ACETYLATION; HISTONE MODIFICATION; MOLECULAR PROBE; NONHUMAN; PERSONAL EXPERIENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PSYCHOPATHY; PSYCHOSIS; RETT SYNDROME; SUICIDE; TRANSCRIPTION REGULATION; VALIDATION STUDY; ANIMAL; ANIMAL MODEL; CHROMATIN; GENETIC EPIGENESIS; HUMAN;

ANIMALS; CHROMATIN; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION; HISTONES; HUMANS; MODELS, ANIMAL;

EID: 84865818829     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2010_104     Document Type: Article

References (173)

1. Adams-Cioaba MA, Min J (2009) Structure and function of histone methylation binding proteins. Biochem Cell Biol 87(1):93-105
2. Adcock IM (2007) HDAC inhibitors as anti-inflammatory agents. Br J Pharmacol 150(7):829-831
3. Ahmed SH, Koob GF (1997) Cocaine- but not food-seeking behavior is reinstated by stress after extinction. Psychopharmacology (Berl) 132(3):289-295
4. Alexander VM, Roy M et al (2010) Azacytidine induces cell cycle arrest and suppression of neuroendocrine markers in carcinoids. Int J Clin Exp Med 3(2):95-102
5. Amir RE, Van den Veyver IB et al (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23(2):185-188
6. Bannister AJ, Kouzarides T (2005) Reversing histone methylation. Nature 436(7054):1103-1106
7. Bannister AJ, Zegerman P et al (2001) Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410(6824):120-124
8. Barrot M, Olivier JD et al (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci USA 99(17):11435-11440
9. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2):281-297
10. Bartel DP, Chen CZ (2004) Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 5(5):396-400
11. Berton O, McClung CA et al (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311(5762):864-868
12. Biswas SK, Lewis CE (2010) NF-{kappa}B as a central regulator of macrophage function in tumors. J Leukoc Biol 88(5):877-884
13. Blackledge NP, Klose R (2010) Histone lysine methylation: an epigenetic modification? Epigenomics 2(1):151-161
14. Borrelli E, Nestler EJ et al (2008) Decoding the epigenetic language of neuronal plasticity. Neuron 60(6):961-974
15. Bradner JE, West N et al (2009) Chemical phylogenetics of histone deacetylases. Nat Chem Biol 6(3):238-243
16. Brami-Cherrier K, Roze E et al (2009) Role of the ERK/MSK1 signalling pathway in chromatin remodelling and brain responses to drugs of abuse. J Neurochem 108(6):1323-1335
17. Brown P, Hunger SP et al (2009) Novel targeted drug therapies for the treatment of childhood acute leukemia. Expert Rev Hematol 2(9):145
18. Budden SS, Dorsey HC et al (2005) Clinical profile of a male with Rett syndrome. Brain Dev 27(Suppl 1):S69-S71
19. Carlezon WA Jr, Thome J et al (1998) Regulation of cocaine reward by CREB. Science 282 (5397):2272-2275
20. Carney RM, Wolpert CM et al (2003) Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr Neurol 28(3):205-211
21. Cavalleri GL, Walley NM et al (2007) A multicenter study of BRD2 as a risk factor for juvenile myoclonic epilepsy. Epilepsia 48(4):706-712
22. Champagne DL, Bagot RC et al (2008) Maternal care and hippocampal plasticity: evidence for experience-dependent structural plasticity, altered synaptic functioning, and differential responsiveness to glucocorticoids and stress. J Neurosci 28(23):6037-6045
23. Chen RZ, Akbarian S et al (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat Genet 27(3):327-331
24. Chen GG, Chak EC et al (2003a) Glioma apoptosis induced by macrophages involves both death receptor-dependent and independent pathways. J Lab Clin Med 141(3):190-199
25. Chen WG, Chang Q et al (2003b) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302(5646):885-889
26. Collins AL, Levenson JM et al (2004) Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 13(21):2679-2689
27. Collins RE, Northrop JP et al (2008) The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules. Nat Struct Mol Biol 15(3):245-250
28. Covington HE 3rd, Maze I et al (2009) Antidepressant actions of histone deacetylase inhibitors. J Neurosci 29(37):11451-11460
29. Culhane JC, Wang D et al (2010) Comparative analysis of small molecules and histone substrate analogues as LSD1 lysine demethylase inhibitors. J Am Chem Soc 132(9):3164-3176
30. Dashwood RH, Ho E (2007) Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol 17(5):363-369
31. Davis CD, Uthus EO (2004) DNA methylation, cancer susceptibility, and nutrient interactions. Exp Biol Med (Maywood) 229(10):988-995
32. Dayer AG, Bottani A et al (2007) MECP2 mutant allele in a boy with Rett syndrome and his unaffected heterozygous mother. Brain Dev 29(1):47-50
33. Dhalluin C, Carlson JE et al (1999) Structure and ligand of a histone acetyltransferase bromodomain. Nature 399(6735):491-496
34. Dong E, Agis-Balboa RC et al (2005) Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia. Proc Natl Acad Sci USA 102(35):12578-12583
35. Dong J, Jimi E et al (2010) Constitutively active NF-kappaB triggers systemic TNFalpha-dependent inflammation and localized TNFalpha-independent inflammatory disease. Genes Dev 24(16):1709-1717
36. Edwards AM, Bountra C et al (2009) Open access chemical and clinical probes to support drug discovery. Nat Chem Biol 5(7):436-440
37. Erb S, Shaham Y et al (1996) Stress reinstates cocaine-seeking behavior after prolonged extinction and a drug-free period. Psychopharmacology (Berl) 128(4):408-412
38. Escoubet-Lozach L, Lin IL et al (2009) Pomalidomide and lenalidomide induce p21 WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism. Cancer Res 69(18):7347-7356
39. Fan G, Hutnick L (2005) Methyl-CpG binding proteins in the nervous system. Cell Res 15 (4):255-261
40. Feng J, Sun G et al (2009) Evidence for X-chromosomal schizophrenia associated with microRNA alterations. PLoS One 4(7):e6121
41. Ferraris DV (2010) Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic. J Med Chem 53(12):4561-4584
42. Florence B, Faller DV (2001) You bet-cha: a novel family of transcriptional regulators. Front Biosci 6:D1008-D1018
43. Fog CK, Jensen KT et al (2007) Chromatin-modifying proteins in cancer. APMIS 115 (10):1060-1089
44. Francis D, Diorio J et al (1999) Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science 286(5442):1155-1158
45. Fuks F, Hurd PJ et al (2003) The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J Biol Chem 278(6):4035-4040
46. Giacometti E, Luikenhuis S et al (2007) Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc Natl Acad Sci USA 104(6):1931-1936
47. Goll MG, Bestor TH (2005) Eukaryotic cytosine methyltransferases. Annu Rev Biochem 74:481-514
48. Grayson DR, Kundakovic M et al (2008) Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders? Mol Pharmacol 77(2):126-135
49. Green TA, Alibhai IN et al (2006) Induction of inducible cAMP early repressor expression in nucleus accumbens by stress or amphetamine increases behavioral responses to emotional stimuli. J Neurosci 26(32):8235-8242
50. Greiner D, Bonaldi T et al (2005) Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat Chem Biol 1(3):143-145
51. Grozinger CM, Chao ED et al (2001) Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J Biol Chem 276(42):38837-38843
52. Guan JS, Haggarty SJ et al (2009) HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 459(7243):55-60
53. Guy J, Hendrich B et al (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27(3):322-326
54. Guy J, Gan J et al (2007) Reversal of neurological defects in a mouse model of Rett syndrome. Science 315(5815):1143-1147
55. Hahnen E, Hauke J et al (2008) Histone deacetylase inhibitors: possible implications for neurodegenerative disorders. Expert Opin Investig Drugs 17(2):169-184
56. Hammond SM, Caudy AA et al (2001) Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet 2(2):110-119
57. Hassa PO, Haenni SS et al (2006) Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going? Microbiol Mol Biol Rev 70(3):789-829
58. Hassan YI, Zempleni J (2008) A novel, enigmatic histone modification: biotinylation of histones by holocarboxylase synthetase. Nutr Rev 66(12):721-725
59. Healy S, Heightman TD et al (2009) Nonenzymatic biotinylation of histone H2A. Protein Sci 18(2):314-328
60. Heidbreder C (2011) Advances in animal models of drug addiction. Springer, Heidelberg. doi:10.1007/7854_2010_107
61. Heltweg B, Gatbonton T et al (2006) Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res 66(8):4368-4377
62. Hooker J, Kim SW et al (2010) Histone deacetylase inhibitor MS-275 exhibits poor brain penetration: pharmacokinetic studies of [11C]MS-275 using positron emission tomography. ACS Chem Neurosci 1(1):65-73
63. Hrzenjak A, Moinfar F et al (2010) Histone deacetylase inhibitor vorinostat suppresses the growth of uterine sarcomas in vitro and in vivo. Mol Cancer 9:49
64. Huang B, Yang XD et al (2009) Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol Cell Biol 29(5):1375-1387
65. Huang Y, Pastor WA et al (2010) The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 5(1):e8888
66. Hyman SE, Malenka RC et al (2006) Neural mechanisms of addiction: the role of reward-related learning and memory. Annu Rev Neurosci 29:565-598
67. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl):245-254
68. Jan MM, Dooley JM et al (1999) Male Rett syndrome variant: application of diagnostic criteria. Pediatr Neurol 20(3):238-240
69. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293(5532):1074-1080
70. Kim IA, Kim IH et al (2010) HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon? J Radiat Res (Tokyo) 51(3):257-263
71. Klauck SM, Lindsay S et al (2002) A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome. Am J Hum Genet 70(4):1034-1037
72. Klose RJ, Bird AP (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31(2):89-97
73. Koob G, Kreek MJ (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164(8):1149-1159
74. Kouzarides T (2007) Chromatin modifications and their function. Cell 128(4):693-705
75. Kovacheva VP, Mellott TJ et al (2007) Gestational choline deficiency causes global and Igf2 gene DNA hypermethylation by up-regulation of Dnmt1 expression. J Biol Chem 282(43): 31777-31788
76. Kriaucionis S, Bird A (2003) DNA methylation and Rett syndrome. Hum Mol Genet 12 Spec No 2: R221-R227
77. Kriaucionis S, Heintz N (2009) The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324(5929):929-930
78. Kubicek S, O'Sullivan RJ et al (2007) Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase. Mol Cell 25(3):473-481
79. Kumar A, Choi KH et al (2005) Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron 48(2):303-314
80. Lachner M, O'Carroll D et al (2001) Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410(6824):116-120
81. Lam CW, Yeung WL et al (2000) Spectrum of mutations in the MECP2 gene in patients with infantile autism and Rett syndrome. J Med Genet 37(12):E41
82. Langereis JD, Raaijmakers HA et al (2010) Abrogation of NF-{kappa}B signaling in human neutrophils induces neutrophil survival through sustained p38-MAPK activation. J Leukoc Biol 88:655-664
83. Lau OD, Kundu TK et al (2000) HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol Cell 5(3):589-595
84. Lee MG, Wynder C et al (2006) Histone H3 lysine 4 demethylation is a target of nonselective antidepressive medications. Chem Biol 13(6):563-567
85. Lee JH, Choy ML et al (2010) Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair. Proc Natl Acad Sci USA 107(33):14639-14644
86. Levenson JM, Sweatt JD (2005) Epigenetic mechanisms in memory formation. Nat Rev Neurosci 6(2):108-118
87. Li X, Chen BD (2009) Histone deacetylase inhibitor M344 inhibits cell proliferation and induces apoptosis in human THP-1 leukemia cells. Am J Biomed Sci 1(4):352-363
88. Li E, Bestor TH et al (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69(6):915-926
89. Lister R, Pelizzola M et al (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462(7271):315-322
90. Liu D, Diorio J et al (1997) Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 277(5332):1659-1662
91. Liu F, Chen X et al (2009) Discovery of a 2, 4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a. J Med Chem 52(24):7950-7953
92. Loenarz C, Schofield CJ (2009) Oxygenase catalyzed 5-methylcytosine hydroxylation. Chem Biol 16(6):580-583
93. Luthi-Carter R, Taylor DM et al (2010) SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis. Proc Natl Acad Sci USA 107(17):7927-7932
94. Ma X, Ezzeldin HH et al (2009) Histone deacetylase inhibitors: current status and overview of recent clinical trials. Drugs 69(14):1911-1934
95. Maiwald R, Bonte A et al (2002) De novo MECP2 mutation in a 46, XX male patient with Rett syndrome. Neurogenetics 4(2):107-108
96. Mantelingu K, Reddy BA et al (2007) Specific inhibition of p300-HAT alters global gene expression and represses HIV replication. Chem Biol 14(6):645-657
97. Manzo F, Tambaro FP et al (2009) Histone acetyltransferase inhibitors and preclinical studies. Expert Opin Ther Pat 19(6):761-774
98. Masuyama T, Matsuo M et al (2005) Classic Rett syndrome in a boy with R133C mutation of MECP2. Brain Dev 27(6):439-442
99. Maze I, Covington HE 3rd et al (2010) Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 327(5962):213-216
100. McGill BE, Bundle SF et al (2006) Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc Natl Acad Sci USA 103(48):18267-18272
101. McGowan PO, Kato T (2008) Epigenetics in mood disorders. Environ Health Prev Med 13 (1):16-24
102. McGowan PO, Meaney MJ et al (2008) Diet and the epigenetic (re)programming of phenotypic differences in behavior. Brain Res 1237:12-24
103. McGowan PO, Sasaki A et al (2009) Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 12(3):342-348
104. Merali Z, Du L et al (2004) Dysregulation in the suicide brain: mRNA expression of corticotrophin-releasing hormone receptors and GABA(A) receptor subunits in frontal cortical brain region. J Neurosci 24(6):1478-1485
105. Metzger E, Wissmann M et al (2005) LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature 437(7057):436-439
106. Metzger E, Yin N et al (2008) Phosphorylation of histone H3 at threonine 11 establishes a novel chromatin mark for transcriptional regulation. Nat Cell Biol 10(1):53
107. Milani D, Pantaleoni C et al (2005) Another patient with MECP2 mutation without classic Rett syndrome phenotype. Pediatr Neurol 32(5):355-357
108. Minsky N, Shema E et al (2008) Monoubiquitinated H2B is associated with the transcribed region of highly expressed genes in human cells. Nat Cell Biol 10(4):483-488
109. Mitsubishi/Tanabe (Int. Pat. Appl. WO09/084693)
110. Moretti P, Bouwknecht JA et al (2005) Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome. Hum Mol Genet 14(2):205-220
111. Need AC, Ge D et al (2009) A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet 5(2):e1000373
112. Ng HH, Bird A (1999) DNA methylation and chromatin modification. Curr Opin Genet Dev 9 (2):158-163
113. Ng SS, Kavanagh KL et al (2007) Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity. Nature 448(7149):87
114. Niculescu MD, Craciunescu CN et al (2006) Dietary choline deficiency alters global and genespecific DNA methylation in the developing hippocampus of mouse fetal brains. FASEB J 20 (1):43-49
115. Nuber UA, Kriaucionis S et al (2005) Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum Mol Genet 14(15):2247-2256
116. Outeiro TF, Kontopoulos E et al (2007) Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease. Science 317(5837):516-519
117. Pacholec M, Bleasdale JE et al (2010) SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 285(11):8340-8351
118. Pagans S, Pedal A et al (2005) SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol 3(2):e41
119. Palmieri D, Lockman PR et al (2009) Vorinostat inhibits brain metastatic colonization in a model of triple-negative breast cancer and induces DNA double-strand breaks. Clin Cancer Res 15 (19):6148-6157
120. Paris M, Porcelloni M et al (2008) Histone deacetylase inhibitors: from bench to clinic. J Med Chem 51(6):1505
121. Penn NW, Suwalski R et al (1972) The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. Biochem J 126(4):781-790
122. Perez Fidalgo JA, Roda D et al (2009) Aurora kinase inhibitors: a new class of drugs targeting the regulatory mitotic system. Clin Transl Oncol 11(12):787
123. Petronis A (2010) Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 465(7299):721-727
124. Pogribny IP, Ross SA et al (2006) Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency. Mutat Res 593(1-2):80-87
125. Poulter MO, Du L et al (2008) GABAA receptor promoter hypermethylation in suicide brain: implications for the involvement of epigenetic processes. Biol Psychiatry 64(8):645-652
126. Quinn AM, Bedford MT et al (2009) A homogeneous method for investigation of methylation-dependent protein-protein interactions in epigenetics. Nucleic Acids Res 38(2):e11
127. Renthal W, Maze I et al (2007) Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron 56(3):517-529
128. Renthal W, Carle TL et al (2008) Delta FosB mediates epigenetic desensitization of the c-fos gene after chronic amphetamine exposure. J Neurosci 28(29):7344-7349
129. Renthal W, Kumar A et al (2009) Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron 62(3):335-348
130. Robinson TE, Kolb B (2004) Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 47(Suppl 1):33-46
131. Rose NR, Ng SS et al (2008) Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases. J Med Chem 51(22):7053-7056
132. Rose NR, Woon EC et al (2010) Selective inhibitors of the JMJD2 histone demethylases: combined nondenaturing mass spectrometric screening and crystallographic approaches. J Med Chem 53(4):1810-1818
133. Ross SA (2003) Diet and DNA methylation interactions in cancer prevention. Ann N Y Acad Sci 983:197-207
134. Ross SA, Milner JA (2007) Epigenetic modulation and cancer: effect of metabolic syndrome? Am J Clin Nutr 86(3):s872-s877
135. Russo SJ, Mazei-Robison MS et al (2009) Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56(Suppl 1):73-82
136. Sachchidanand, Resnick-Silverman L et al (2006) Target structure-based discovery of small molecules that block human p53 and CREB binding protein association. Chem Biol 13 (1):81-90
137. Sakurai M, Rose NR et al (2010) A miniaturized screen for inhibitors of Jumonji histone demethylases. Mol Biosyst 6(2):357-364
138. Schroeder FA, Lin CL et al (2007) Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry 62(1):55-64
139. Shahbazian M, Young J et al (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron 35(2):243-254
140. Shiio Y, Eisenman RN (2003) Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci USA 100(23):13225
141. Sleutels F, Zwart R et al (2002) The non-coding air RNA is required for silencing autosomal imprinted genes. Nature 415(6873):810-813
142. Slyshenkov VS, Shevalye AA et al (2002) Protective role of L-methionine against free radical damage of rat brain synaptosomes. Acta Biochim Pol 49(4):907-916
143. Smiraglia DJ, Rush LJ et al (2001) Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 10(13):1413-1419
144. Stimson L, Rowlands MG et al (2005) Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity. Mol Cancer Ther 4(10):1521-1532
145. Stipanovich A, Valjent E et al (2008) A phosphatase cascade by which rewarding stimuli control nucleosomal response. Nature 453(7197):879-884
146. Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403(6765): 41-45
147. Suganuma T, Workman JL (2008) Crosstalk among histone modifications. Cell 135(4):604-607
148. Swinney DC, Xu YZ et al (2002) A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats. J Biol Chem 277(26):23573
149. Szyf M (2009) Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol 49:243-263
150. Tahiliani M, Koh KP et al (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929):930-935
151. Takai N, Narahara H (2010) Histone deacetylase inhibitor therapy in epithelial ovarian cancer. J Oncol 2010:458431
152. Tan J, Cang S et al (2010) Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents. J Hematol Oncol 3:5
153. Taverna SD, Li H et al (2007) How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol 14(11):1025-1040
154. Tremolizzo L, Carboni G et al (2002) An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc Natl Acad Sci USA 99(26): 17095-17100
155. Tremolizzo L, Doueiri MS et al (2005) Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice. Biol Psychiatry 57(5):500-509
156. Tsankova NM, Berton O et al (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9(4):519-525
157. Tsankova N, Renthal W et al (2007) Epigenetic regulation in psychiatric disorders. Nat Rev Neurosci 8(5):355-367
158. Tueting P, Doueiri MS et al (2006) Reelin down-regulation in mice and psychosis endophenotypes. Neurosci Biobehav Rev 30(8):1065-1077
159. Van den Veyver IB (2002) Genetic effects of methylation diets. Annu Rev Nutr 22:255-282
160. Voso MT, Santini V et al (2009) Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. Clin Cancer Res 15(15): 5002-5007
161. Waddington CH (1957) The strategy of the Genes: a Discussion of Some Aspects of Theoretical Biology. Allen and Unwin, London
162. Wang H, Dymock BW (2009) New patented histone deacetylase inhibitors. Expert Opin Ther Pat 19(12):1727-1757
163. Watson P, Black G et al (2001) Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet 38(4):224-228
164. Weaver IC, Cervoni N et al (2004) Epigenetic programming by maternal behavior. Nat Neurosci 7(8):847-854
165. Weaver IC, Champagne FA et al (2005) Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life. J Neurosci 25(47):11045-11054
166. Weaver IC, Meaney MJ et al (2006) Maternal care effects on the hippocampal transcriptome and anxiety-mediated behaviors in the offspring that are reversible in adulthood. Proc Natl Acad Sci USA 103(9):3480-3485
167. Wigle TJ, Herold JM et al (2010) Screening for inhibitors of low-affinity epigenetic peptide-protein interactions: an AlphaScreen-based assay for antagonists of methyl-lysine binding proteins. J Biomol Screen 15(1):62-71
168. Wyatt A, Benedict RG, Davis J (1971) Biochemical and sleep studies of schizophrenia: a review of the literature - 1960-1970. Schizophr Bull 4:10-44
169. Yang M, Culhane JC et al (2007) Structural basis for the inhibition of the LSD1 histone demethylase by the antidepressant trans-2-phenylcyclopropylamine. Biochemistry 46(27): 8058-8065
170. Yoshida M, Kijima M et al (1990) Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J Biol Chem 265(28):17174-17179
171. Zhou Z, Hong EJ et al (2006) Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation. Neuron 52(2):255-269
172. Zhu X, Ma Y et al (2010) Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights. J Hematol Oncol 3:17
173. Zippo A, Serafini R et al (2009) Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 138(6):1122